Vancomycin in hepatic dysfunction: population estimates drifted — check levels early

Design

Multicentre retrospective observational study

Population

157 adults on vancomycin (63 with hepatic dysfunction and albumin <2 g/dL)

Primary outcome

AUC deviation ≥30% between population and Bayesian estimates

Effect

Hepatic dysfunction aOR 2.26 (95% CI 1.10–4.62)

A multicentre retrospective study in Therapeutic Drug Monitoring included 157 adults given vancomycin with measured troughs, 63 of whom had hepatic dysfunction (cirrhosis, hepatic failure or other liver disease) with albumin below 2 g/dL. The investigators compared AUC estimated from population parameters with AUC estimated by Bayesian methods using measured concentrations.

Hepatic dysfunction was independently associated with a deviation of 30% or more between the two estimates (aOR 2.26, 95% CI 1.10–4.62). Patients with hepatic dysfunction had higher actual AUC and higher trough ratios than predicted. The likely mechanism is low creatinine generation, which inflates estimated clearance and leads to dose regimens that overshoot.

Vancomycin AUC-guided dosing is increasingly standard, but the population models it starts from assume creatinine reflects kidney function. In patients with cirrhosis and low albumin, that assumption fails. The practical response is to obtain levels early rather than relying on the initial model, and to adjust promptly. The study is retrospective and small, and did not measure clinical outcomes such as nephrotoxicity.

• In patients with liver disease and low albumin, check vancomycin levels early — after the first or second dose where feasible.
• Expect higher exposure than population-based dosing predicts.
• Use Bayesian dosing software with measured levels where available.
• Monitor creatinine and urine output closely; nephrotoxicity risk rises with exposure.

Why it matters

It shows where AUC-guided dosing quietly fails: the patient whose creatinine is low for the wrong reason.

Don't overread it

This retrospective study shows model mismatch, not that early monitoring reduces kidney injury.

The statistics, in plain English

An adjusted odds ratio of 2.26 means the odds of a large estimation error were more than doubled in hepatic dysfunction. The wide interval (1.10–4.62) reflects the small sample.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.